Barclays maintains Intl Flavors & Fragrances at Overweight, lowers price target to $103 from $105

Barclays kept Intl Flavors & Fragrances (IFF) at Overweight but reduced its price target to $103 from $105. This implies a 19.3% upside from the Nov 5 close of $86.36. Recent analyst price targets for IFF range from $95 to $108.

Original reporting
Published Nov 6, 2026, 4:13 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 6, 2026, 4:17 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Barclays maintains Intl Flavors & Fragrances at Overweight, lowers price target to $103 from $105 — source image
Decision brief

The 30-second read

$IFFBearishLow
01

Why it matters

The downgrade may lead to short-term selling pressure, but the Overweight stance suggests the firm still expects outperformance relative to peers.

02

Market read

Analyst target adjustment provides a modest trading signal for IFF; limited broader market impact.

03

What to watch

Potential upside from upcoming fragrance contracts not reflected in the target.

Relevance 5/10Novelty 4/10Timing: today

Background

Barclays maintains an Overweight rating but trims its price target, implying a modest upside from current price.

Company-level read

Ticker impact

$IFFBearishMedium confidence
Context

Barclays lowered its price target for International Flavors & Fragrances to $103 from $105.

Expected impact

likely downside as investors price in lower expectations

Evidence & confidence

Target reduction signals weaker outlook; no new corporate event, only analyst opinion.

Market effects

Minor impact on the consumer goods sector; analyst revisions may affect peers.

U.S. market focus; limited regional effect.

Low global relevance; only affects IFF and close competitors.

Counterpoint

The target cut may be overly cautious; recent product launches could support higher valuation.

Key entities

  • International Flavors & Fragrances Inc.

    Global manufacturer of flavors and fragrances, ticker IFF.

  • Barclays

    Investment bank providing the rating and price target.

Related articles

$IFFMedAI 8/10

International Flavors & Fragrances Q3 Earnings Call Highlights

International Flavors & Fragrances (IFF) reported Q3 sales of $566M in Health & Biosciences, up 1%. Full-year sales are expected to be $7.5B-$7.6B, with adjusted EBITDA of $1.55B-$1.6B. IFF faces cost pressures, particularly in Health & Biosciences, due to higher input costs. The company plans to divest its Food Ingredients business for $4.3B by mid-2027 and has completed other divestitures. Free cash flow for the first nine months of 2026 was $371M, up $245M year-over-year.

$IFFMed

International Flavors & Fragrances Inc (IFF) (Q3 2026) Earnings Call

International Flavors & Fragrances Inc (IFF) reported challenges in its Health business due to reduced consumer spending in the US and Europe. The company expects higher costs in Q4 2026, with net price to input costs remaining unfavorable. Profitability margins are expected to moderate due to seasonality and higher costs. IFF faces execution risks related to the separation of its Food Ingredients business.

$IFFHigh

BofA downgrades International Flavors & Fragrances stock rating on valuation concerns

BofA downgraded International Flavors & Fragrances (IFF) to Underperform, lowering its price target to $91. IFF reported Q3 adjusted EBITDA of $403M, beating estimates. Despite strong results, BofA cited valuation concerns, softness in non-Taste businesses, and rising costs. IFF's stock declined post-earnings due to near-term margin concerns, though management raised full-year guidance.

$IFFHighAI 8/10

Intl Flavors (IFF) Q3 2026 Earnings Call Transcript

Intl Flavors (IFF) reported Q3 2026 earnings with 5% revenue growth and 6% EBITDA increase, driven by strong performances in taste and scent segments. The company raised its full-year guidance, completed a $500M share repurchase, and announced strategic divestitures, including the sale of its food ingredients business for $4.3B. Free cash flow rose to $371M, up $245M YoY. IFF expects near-term softness in Health & Biosciences but remains confident in its growth strategy.

$IFFMedAI 9/10

IFF Q3 2026 slides: solid growth tempered by margin headwinds

International Flavors & Fragrances (IFF) reported Q3 2026 earnings with revenue of $1.94B and adjusted EPS of $0.83, beating expectations. Shares fell 3.83% due to margin concerns and guidance for softer Q4 profitability. IFF highlighted growth in Taste, Scent, and Health & Biosciences segments, along with a $4.3B sale of its Food Ingredients business and a $2.5B capital return program. Free cash flow improved to $371M, up $245M YoY.